2 min read
RAPS US Convergence
Meet Veristat at RAPS US Convergence 2025
Where Regulatory Excellence Meets Real-World Impact
Veristat is delighted...
As you look to transition your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
We provide impactful solutions on both a full-service or functional service basis, including strategic regulatory guidance, clinical program design, and IND/CTA support through to successful regulatory approval.
We are pleased to announce that Montse Barceló Riera M.D., Vice President of Europe at Veristat, will be a speaker at the plenary session, The Patient Voice as a Starting and Ending Point for the Development of New Innovative Healthcare Solutions.
Panel Summary:
Moderator:
Jose Maria Gimenez Arnau, Chief Scientific & Medical Officer, ESTEVE Healthcare
Speakers:
Fulvio Capitanio, member of the World Parkinson Coalition 2023 Steering Committee, Barcelona
Carmen Rios Benton, Founder Doctomatic. Member Board Tech Barcelona
Begoña Nafría Escalera, Patient engagement & Research coordinator, Hospital Sant Joan de Déu, Barcelona. Coordinator eYPAGnet
Montse Barceló Riera, VP Europe Veristat
Veristat team members, Montse Barceló Riera MD, VP Europe, and Balma Gil, Business Development, will be at the venue, ready to listen to your needs and share Veristat’s expertise.
If you would like to meet us at BIOSPAIN 2023, feel free to contact us to arrange a meeting through the form.
Website: BIOSPAIN 2023
2 min read
Sep 10, 2025 Veristat Events
Veristat is delighted...
5 min read
Aug 28, 2025 Veristat Events